SSAO and Aβ in the vascular damage of the temporal cortex from Alzheimer and Alzheimer with diabetes patients

[1]  R. Armstrong,et al.  A spatial pattern analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease. , 2010, Folia neuropathologica.

[2]  N. Durany,et al.  Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus , 2010, Neurobiology of Disease.

[3]  Seong Jin Cho,et al.  Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease , 2008, NeuroImage.

[4]  R. Jailkhani,et al.  Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients , 2008, Acta Diabetologica.

[5]  P. Yu,et al.  Potential implications of endogenous aldehydes in β‐amyloid misfolding, oligomerization and fibrillogenesis , 2006, Journal of neurochemistry.

[6]  A. Somogyi,et al.  Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats , 2006, Neurochemistry International.

[7]  J. Lizcano,et al.  Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer’s disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy , 2002, Neuroscience Letters.

[8]  Philip S. Yu,et al.  Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications. , 1999, Journal of chromatographic science.

[9]  K. Tipton,et al.  Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. , 1998, The Biochemical journal.

[10]  P. Yu,et al.  Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. , 1996, Atherosclerosis.

[11]  A. J. Man in 't Veld,et al.  Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. , 1995, Clinical science.

[12]  Philip S. Yu,et al.  Oxidative Deamination of Methylamine by Semicarbazide-Sensitive Amine Oxidase Leads to Cytotoxic Damage in Endothelial Cells: Possible Consequences for Diabetes , 1993, Diabetes.

[13]  F. Ishizaki.  Plasma benzylamine oxidase activity in cerebrovascular disease. , 1990, European neurology.